Protagenic Therapeutics
(PTIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 5,701 | 4,527 | 3,558 | 4,140 | 2,552 |
| Operating Income | -5,701 | -4,527 | -3,558 | -4,140 | -2,552 |
| Interest Expense | 0 | 108 | 138 | 497 | 246 |
| Other Income | 176 | -366 | 140 | 114 | 249 |
| Pre-tax Income | -5,525 | -5,001 | -3,556 | -4,523 | -2,549 |
| Net Income Continuous | -5,525 | -5,001 | -3,556 | -4,523 | -2,549 |
| Net Income | $-5,525 | $-5,001 | $-3,556 | $-4,523 | $-2,549 |
| EPS Basic Total Ops | -15.83 | -16.11 | -11.48 | -17.37 | -14.01 |
| EPS Basic Continuous Ops | -15.79 | -16.12 | -11.53 | -17.19 | -13.81 |
| EPS Diluted Total Ops | -15.83 | -16.11 | -11.48 | -17.37 | -14.01 |
| EPS Diluted Continuous Ops | -15.79 | -16.12 | -11.53 | -17.19 | -13.81 |
| EPS Diluted Before Non-Recurring Items | -15.83 | -16.11 | N/A | -17.37 | -14.01 |
| EBITDA(a) | $-5,651 | $-4,413 | $-3,447 | $-3,713 | $-2,396 |